This fact sheet discusses cannabis health risks based on frequency of use, the form consumed, and a patient’s other therapies ...

Evidence suggests repeated low-level red light therapy for pediatric myopia management may risk cone photoreceptor loss.

As of mid-May, this variant has been identified in nearly 11 percent of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently ...

The top US health agency will no longer recommend the COVID-19 vaccine for healthy children and pregnant women.

Patients with glaucoma often demonstrate poor adherence to prescribed treatment plans with prostaglandin analogues, which decreases over time.

Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.

For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compared with dipeptidyl peptidase-4 (DPP-4) ...

Compared with single-vision lens wear, 2 years of orthokeratology lens wear can slow axial elongation for at least 11 years ...

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

Epi-on demonstrates a more favorable safety profile than epi-off corneal cross-linking in patients with corneal ectasia.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...